Price-Fixing: Steakhouse Dinner, Emails Do Not Show Conspiracy, Generic Firms Contend
Executive Summary
Companies argue why 40 US attorneys general have no antitrust case against them in joint and individual motions to dismiss complaint.
You may also be interested in...
Insulin Pricing, PBM Relationships Under Government Microscope
Minnesota Attorney General demands Novo Nordisk and Sanofi provide information on their insulin pricing; they are also among several companies facing probes over their contracts with pharmacy benefit managers.
Generic Industry Hit With Avalanche Of Price Fixing Suits
As state attorneys general and Department of Justice move against generic manufacturers, plaintiffs’ firms have filed more than 90 antitrust suits on behalf of third party payers.
Generic Price Fixing Probe: First Charges Unsealed, More May Come Before Inauguration Day
Heritage Pharmaceuticals’ former CEO and former president charged by US DOJ with conspiracy to fix prices and allocate customers for doxycycline and glyburide; Heritage alleges they embezzled intellectual property.